When I was diagnosed with Parkinson’s in August 2019, a doctor told me that Sinemet (Levodopa/Carbidopa), the starter drug of ...

Management of axial signs (postural instability, freezing) and cognitive decline in Parkinson's disease is unsatisfactory with the current medical treatment. Subthalamic nucleus stimulation is an ...

Researchers have identified a protein, TMEM16F, that appears to aid the spread of Parkinson’s pathology in the brain.

A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has identified a potential biomarker of Parkinson's disease progression.

A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has ...

Aug. 19, 2024 — A small feasibility study found that an implanted device regulated by the body's brain activity could provide continual and improved treatment for the symptoms of Parkinson's ...

for adults living with advanced Parkinson's disease (PD). Vyalev is the first and only subcutaneous 24-hour continuous infusion of levodopa-based therapy for the treatment of motor fluctuations in ...

The Food and Drug Administration approved a drug produced by AbbVie for the treatment of late stage Parkinsons disease the company announced Thursday. The regulator approved Vyalev, also known as ...

Parkinson's disease and ADHD are genetically linked, finds a brain study that could provide a roadmap for future treatment.

Researchers have reported that early exposure to a few antimicrobials, like penicillins and antifungals, could impact the ...